DCTH trading ideaIt appears triangle is forming in wave 4. which is about to complete. Based on it, we can have some trade plan Buy DCTH at 0.1273, stop loss 0.1183, target 0.2571 and above, check red lines for 3 upside targets
Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.